Skip to main content

Healthpeak Properties Outpatient Medical Buildings revenue

  • DOC · NYSE
  • Real estate
  • Health Care REITs
  • S&P 500
$19.98−0.70%Close 13 Nov 2026 · Market value $13.57B

Outpatient Medical Buildings revenue at Healthpeak Properties came to $326.6M for the quarter to 30 Sep 2025, up 2.8% from a year earlier.

As Healthpeak Properties reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 24 Oct 2025.

By quarter

$179.3MJun 2022$184.5MSep 2022$187.0MMar 2023$186.7MJun 2023$191.0MSep 2023$238.3MMar 2024$332.5MJun 2024$317.7MSep 2024$320.5MMar 2025$320.5MJun 2025$326.6MSep 2025
Healthpeak Properties Outpatient Medical Buildings revenue, every reported period
Period endingOutpatient Medical Buildings revenueChange on a yearFiled
30 Sep 2025$326.6Mup 2.8%24 Oct 2025
30 Jun 2025$320.5Mdown 3.6%25 Jul 2025
31 Mar 2025$320.5Mup 34.5%25 Apr 2025
30 Sep 2024$317.7Mup 66.3%25 Oct 2024
30 Jun 2024$332.5Mup 78.1%26 Jul 2024
31 Mar 2024$238.3Mup 27.4%26 Apr 2024
30 Sep 2023$191.0Mup 3.5%30 Oct 2023
30 Jun 2023$186.7Mup 4.1%28 Jul 2023
31 Mar 2023$187.0M—28 Apr 2023
30 Sep 2022$184.5M—2 Nov 2022
30 Jun 2022$179.3M—3 Aug 2022

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Healthpeak Properties: Prior quarter three-month SS property count (Sequential SS, Outpatient Medical) · Current quarter three-month SS property count (Sequential SS, Outpatient Medical) · REVPOR Life Plan average occupied units/month · REVPOR Other average occupied units/month · Transaction and merger-related items · Outpatient medical revenue · Senior housing revenue · Lab revenue · financial statements

Every KPI and segment of DOC, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.